95 related articles for article (PubMed ID: 21574884)
21. Limited sampling strategy for mycophenolic acid in Japanese heart transplant recipients: comparison of cyclosporin and tacrolimus treatment.
Wada K; Takada M; Kotake T; Ochi H; Morishita H; Komamura K; Oda N; Mano A; Kato TS; Hanatani A; Nakatani T
Circ J; 2007 Jul; 71(7):1022-8. PubMed ID: 17587705
[TBL] [Abstract][Full Text] [Related]
22. Limited sampling strategy for the estimation of mycophenolic acid area under the plasma concentration-time curve in adult patients undergoing liver transplant.
Zicheng Y; Weixia Z; Hao C; Hongzhuan C
Ther Drug Monit; 2007 Apr; 29(2):207-14. PubMed ID: 17417076
[TBL] [Abstract][Full Text] [Related]
23. A possible simplification for the estimation of area under the curve (AUC₀₋₁₂) of enteric-coated mycophenolate sodium in renal transplant patients receiving tacrolimus.
Fleming DH; Mathew BS; Prasanna S; Annapandian VM; John GT
Ther Drug Monit; 2011 Apr; 33(2):165-70. PubMed ID: 21383656
[TBL] [Abstract][Full Text] [Related]
24. Population pharmacokinetic analysis of mycophenolic acid coadministered with either tasocitinib (CP-690,550) or tacrolimus in adult renal allograft recipients.
Lamba M; Tafti B; Melcher M; Chan G; Krishnaswami S; Busque S
Ther Drug Monit; 2010 Dec; 32(6):778-81. PubMed ID: 20926996
[TBL] [Abstract][Full Text] [Related]
25. Mycophenolate sodium dosing in combination with tacrolimus: pharmacokinetic evaluation of a novel regimen in de novo tacrolimus-treated kidney transplant patients.
Pons B; Delavenne X; Mehdi M; Maillard N; Sauron C; Berthoux F; Alamartine E; Basset T; Mariat C
Clin Nephrol; 2012 Jun; 77(6):425-31. PubMed ID: 22595383
[TBL] [Abstract][Full Text] [Related]
26. Best single time points to predict the area-under-the-curve in long-term heart transplant patients taking mycophenolate mofetil in combination with cyclosporine or tacrolimus.
Mardigyan V; Giannetti N; Cecere R; Besner JG; Cantarovich M
J Heart Lung Transplant; 2005 Oct; 24(10):1614-8. PubMed ID: 16210138
[TBL] [Abstract][Full Text] [Related]
27. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.
Budde K; Glander P; Krämer BK; Fischer W; Hoffmann U; Bauer S; Grohmann J; Neumayer HH; Arns W
Transplantation; 2007 Feb; 83(4):417-24. PubMed ID: 17318074
[TBL] [Abstract][Full Text] [Related]
28. The pharmacokinetics of mycophenolate mofetil in Thai kidney transplant recipients.
Jirasiritham S; Sumethkul V; Mavichak V; Na-Bangchang K
Transplant Proc; 2004 Sep; 36(7):2076-8. PubMed ID: 15518751
[TBL] [Abstract][Full Text] [Related]
29. [Mycophenolic acid concentration profiles may select recipients with high-risk of acute rejection in renal transplant recipients].
Kuriata-Kordek M; Boratyńska M; Urbaniak J; Woźniak M; Patrzałek D; Szyber P; Klinger M
Pol Merkur Lekarski; 2006 Aug; 21(122):161-3; discussion 164. PubMed ID: 17144102
[TBL] [Abstract][Full Text] [Related]
30. The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy.
Grinyó JM; Ekberg H; Mamelok RD; Oppenheimer F; Sánchez-Plumed J; Gentil MA; Hernandez D; Kuypers DR; Brunet M
Nephrol Dial Transplant; 2009 Jul; 24(7):2269-76. PubMed ID: 19357111
[TBL] [Abstract][Full Text] [Related]
31. Limited sampling model for advanced mycophenolic acid therapeutic drug monitoring after liver transplantation.
Langers P; Press RR; Inderson A; Cremers SC; den Hartigh J; Baranski AG; van Hoek B
Ther Drug Monit; 2014 Apr; 36(2):141-7. PubMed ID: 24081208
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Multiple Linear Regression-Based Limited Sampling Strategies for Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients.
Brooks EK; Tett SE; Isbel NM; McWhinney B; Staatz CE
Ther Drug Monit; 2018 Apr; 40(2):195-201. PubMed ID: 29461443
[TBL] [Abstract][Full Text] [Related]
33. Limited-sampling strategy for mycophenolic acid in renal transplant recipients reciving enteric-coated mycophenolate sodium and tacrolimus.
Sánchez Fructuoso AI; Perez-Flores I; Calvo N; Valero R; Matilla E; Ortega D; Del Dedo MA; Fernández-Pérez C; Barrientos A
Ther Drug Monit; 2012 Jun; 34(3):298-305. PubMed ID: 22549501
[TBL] [Abstract][Full Text] [Related]
34. Abbreviated mycophenolic acid AUC from C0, C1, C2, and C4 is preferable in children after renal transplantation on mycophenolate mofetil and tacrolimus therapy.
Filler G
Transpl Int; 2004 Mar; 17(3):120-5. PubMed ID: 14749919
[TBL] [Abstract][Full Text] [Related]
35. Population Pharmacokinetic Analysis of Immediate-Release Oral Tacrolimus Co-administered with Mycophenolate Mofetil in Corticosteroid-Free Adult Kidney Transplant Recipients.
Rong Y; Mayo P; Ensom MHH; Kiang TKL
Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):409-422. PubMed ID: 30377942
[TBL] [Abstract][Full Text] [Related]
36. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
37. Tacrolimus exposure and mycophenolate pharmacokinetics and pharmacodynamics early after liver transplantation.
Sæves I; Line PD; Bremer S; Vethe NT; Tveit RG; Meltevik TJ; Bergan S
Ther Drug Monit; 2014 Feb; 36(1):46-53. PubMed ID: 24081206
[TBL] [Abstract][Full Text] [Related]
38. A limited sampling strategy for estimating mycophenolic acid area under the curve in adult heart transplant patients treated with concomitant cyclosporine.
Pawinski T; Kunicki PK; Sobieszczanska-Malek M; Gralak B; Szlaska I
J Clin Pharm Ther; 2009 Feb; 34(1):89-101. PubMed ID: 19125907
[TBL] [Abstract][Full Text] [Related]
39. Tacrolimus pharmacokinetic drug interactions: effect of prednisone, mycophenolic acid or sirolimus.
Park SI; Felipe CR; Pinheiro-Machado PG; Garcia R; Fernandes FB; Casarini DE; Tedesco-Silva H; Medina-Pestana JO
Fundam Clin Pharmacol; 2009 Feb; 23(1):137-45. PubMed ID: 19267777
[TBL] [Abstract][Full Text] [Related]
40. Validation of an abbreviated pharmacokinetic profile for the estimation of mycophenolic acid exposure in pediatric renal transplant recipients.
Weber LT; Hoecker B; Armstrong VW; Oellerich M; Tönshoff B
Ther Drug Monit; 2006 Oct; 28(5):623-31. PubMed ID: 17038876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
